CTRI/2013/05/003643招募中4 期
Efficacy and safety of tolvaptan in acute decompensated heart failure - ESTATE-HF
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of either gender above 18 years of age
- •Diagnosis of acute heart failure within 24 hours of presentation to cardio ICU presenting with dyspnea at rest/minimal exertion and at least one of the following
- •Peripheral edema
- •Elevated JVP
- •Pulmonary rales
- •Congestion on Chest X-ray
- •Willing to give informed consent
排除标准
- •Systolic blood pressure < 90 mmHg
- •Serum sodium >136mEq/L
- •Serum creatinine > 3 mg/dl
- •History of acute coronary syndrome in the past 4 weeks
- •Valvular heart disease
- •Pregnant women
- •Breast feeding women
- •Terminal illness due to other causes
研究者
相似试验
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
招募中
不适用
Effect of tolvaptan prodrug in patients with acute heart failure who continue oral tolvaptan therapyAcute heart failureJPRN-UMIN000047646Izumi City General Hospital50
已完成
不适用
Efficacy and safety of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failuresevere chronic kidney disease complicated by congestive heart failureJPRN-UMIN000029787Department of Nephrology, Nippon Medical School50
招募中
1 期
Efficacy and safety of tolvaptan for patients with ascites after liver resection, prospective study(Efficacy and safety of tolvaptan after liver resection, prospective study)JPRN-jRCTs061220114Ohdan Hideki30
招募中
不适用
Efficacy and safety of tolvaptan in patients with severe aortic stenosis and chronic kidney disease undergoing transcatheter aortic valve replacementJPRN-UMIN000033577Tokyo Women's Medical University40